Dongguk University
Also known as: Department of anesthesiology, Dongguk University Il-san hospital | Department of Urology, Dongguk University Gyeongju Hospital | Dept. of anesthesiology and pain medicine, Dongguk University Ilsan Hospital | Donggguk University Ilsan Hospital | DongGuk universit hospital Gyeongju hospital | DongGuk University | Dongguk university Bundang Oriental Hospital | DongGuk University College of Medicine | Dongguk University College of Medicine and Ilsan Hospital | Dongguk University Gyeongju Hospital of Korea | Dongguk University Hospital | Dongguk University Ilsan Hospital, Korea | Dongguk University Ilsan Oriental Hospital | Dongguk University International Hospital | Dongguk University International Hospital, Siksa-dong, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea | Dongguk University Medical Center | Eun Jung Kim | Namyi Gu
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2007Last known activity
May 1, 2024
Timeline
1900s
- Jun 1, 1906
Dongguk University— Founded
Drugs by trial phase (65 distinct, 41 trials)
Phase 4 (22 own, 0 via acquisition)
Phase 3 (25 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Anovulation
- Cancer Pain
- Communicable Diseases
- Cryopyrin-Associated Periodic Syndromes
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Neuropathies
- Dry Eye Syndromes
- Essential Hypertension
- Fatigue
- Gastritis
- Helicobacter Infections
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hernia
- Hyperplasia
- Hypersensitivity
- Hypertension
- Infections
- Infertility
- Keratoconjunctivitis Sicca
- Lung Diseases
- Lung Diseases, Obstructive
- Metabolic Syndrome
- Muscle Spasticity
- Osteoporosis
- Postcholecystectomy Syndrome
- Prehypertension
- Premature Birth
- Prostatic Hyperplasia
- Pulmonary Disease, Chronic Obstructive
- Radiculopathy
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Perennial
- Schizophrenia
- Syndrome
- Vitamin D Deficiency
Recent trials (50)
- NCT06330038CollaboratorPhase 4May 1, 2024
- NCT06438172OfficialPhase 3Mar 25, 2024
- NCT07076628Lead sponsorPhase 4Aug 24, 2023
- NCT07076628Sponsor investigatorPhase 4Aug 24, 2023
- NCT05381194CollaboratorPhase 4Dec 13, 2022
- NCT05362110Overall official - principal investigatorPhase 3May 4, 2022
- NCT04959305Overall official - principal investigatorPhase 2Apr 22, 2021
- NCT03897868Overall official - principal investigatorPhase 2Apr 4, 2019
- NCT04072328Reponsible party - principal investigatorPhase 2Oct 19, 2018
- NCT04072328Lead sponsorPhase 2Oct 19, 2018
- NCT03576235CollaboratorN/AMay 1, 2018
- NCT03479346CollaboratorN/AApr 28, 2018
- NCT03386149CollaboratorPhase 3Dec 28, 2017
- NCT03009136CollaboratorPhase 3Dec 31, 2016
- NCT02844803Sponsor investigatorEarly Phase 1Jul 1, 2016
Details
- Founded
- Seoul, KR Jun 1, 1906
- Last known activity
- May 1, 2024